Global Chondroprotective Agent Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Page: 118

Published Date: 22 Jun 2022

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The Chondroprotective Agent market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Chondroprotective Agent market size is estimated to be worth US$  million in 2021 and is forecast to a readjusted size of USD  million by 2028 with a CAGR of  % during forecast period 2022-2028. Hospital accounting for % of the Chondroprotective Agent global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Sodium Hyaluronate segment is altered to a % CAGR between 2022 and 2028.

Global key manufacturers of Chondroprotective Agent include SANXIN, WanTuMing Biological, TSI Group, Yantai Dongcheng, and Focus Chem, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation
Chondroprotective Agent market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Sodium Hyaluronate
    Glucosamine Sulfate
    Chondroitin Sulfate

Market segment by Application can be divided into
    Hospital
    Ambulatory Surgery Center

The key market players for global Chondroprotective Agent market are listed below:
    SANXIN
    WanTuMing Biological
    TSI Group
    Yantai Dongcheng
    Focus Chem
    YBCC
    Runxin Biotechnology
    ISBA
    Huiwen
    QJBCHINA
    Meitek (Synutra International)
    Hengjie Bio-Pharmaceuticals
    Nippon Zoki
    GGI
    Summit Nutritionals
    Sioux Pharm
    Ruikangda Biochemical
    Guanglong Biochem
    Pacific Rainbow

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Chondroprotective Agent product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Chondroprotective Agent, with price, sales, revenue and global market share of Chondroprotective Agent from 2019 to 2022.
Chapter 3, the Chondroprotective Agent competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Chondroprotective Agent breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Chondroprotective Agent market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Chondroprotective Agent.
Chapter 13, 14, and 15, to describe Chondroprotective Agent sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Chondroprotective Agent Introduction
    1.2 Market Analysis by Type
        1.2.1 Overview: Global Chondroprotective Agent Revenue by Type: 2017 Versus 2021 Versus 2028
        1.2.2 Sodium Hyaluronate
        1.2.3 Glucosamine Sulfate
        1.2.4 Chondroitin Sulfate
    1.3 Market Analysis by Application
        1.3.1 Overview: Global Chondroprotective Agent Revenue by Application: 2017 Versus 2021 Versus 2028
        1.3.2 Hospital
        1.3.3 Ambulatory Surgery Center
    1.4 Global Chondroprotective Agent Market Size & Forecast
        1.4.1 Global Chondroprotective Agent Sales in Value (2017 & 2021 & 2028)
        1.4.2 Global Chondroprotective Agent Sales in Volume (2017-2028)
        1.4.3 Global Chondroprotective Agent Price (2017-2028)
    1.5 Global Chondroprotective Agent Production Capacity Analysis
        1.5.1 Global Chondroprotective Agent Total Production Capacity (2017-2028)
        1.5.2 Global Chondroprotective Agent Production Capacity by Geographic Region
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Chondroprotective Agent Market Drivers
        1.6.2 Chondroprotective Agent Market Restraints
        1.6.3 Chondroprotective Agent Trends Analysis

2 Manufacturers Profiles
    2.1 SANXIN
        2.1.1 SANXIN Details
        2.1.2 SANXIN Major Business
        2.1.3 SANXIN Chondroprotective Agent Product and Services
        2.1.4 SANXIN Chondroprotective Agent Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.2 WanTuMing Biological
        2.2.1 WanTuMing Biological Details
        2.2.2 WanTuMing Biological Major Business
        2.2.3 WanTuMing Biological Chondroprotective Agent Product and Services
        2.2.4 WanTuMing Biological Chondroprotective Agent Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.3 TSI Group
        2.3.1 TSI Group Details
        2.3.2 TSI Group Major Business
        2.3.3 TSI Group Chondroprotective Agent Product and Services
        2.3.4 TSI Group Chondroprotective Agent Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.4 Yantai Dongcheng
        2.4.1 Yantai Dongcheng Details
        2.4.2 Yantai Dongcheng Major Business
        2.4.3 Yantai Dongcheng Chondroprotective Agent Product and Services
        2.4.4 Yantai Dongcheng Chondroprotective Agent Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.5 Focus Chem
        2.5.1 Focus Chem Details
        2.5.2 Focus Chem Major Business
        2.5.3 Focus Chem Chondroprotective Agent Product and Services
        2.5.4 Focus Chem Chondroprotective Agent Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.6 YBCC
        2.6.1 YBCC Details
        2.6.2 YBCC Major Business
        2.6.3 YBCC Chondroprotective Agent Product and Services
        2.6.4 YBCC Chondroprotective Agent Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.7 Runxin Biotechnology
        2.7.1 Runxin Biotechnology Details
        2.7.2 Runxin Biotechnology Major Business
        2.7.3 Runxin Biotechnology Chondroprotective Agent Product and Services
        2.7.4 Runxin Biotechnology Chondroprotective Agent Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.8 ISBA
        2.8.1 ISBA Details
        2.8.2 ISBA Major Business
        2.8.3 ISBA Chondroprotective Agent Product and Services
        2.8.4 ISBA Chondroprotective Agent Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.9 Huiwen
        2.9.1 Huiwen Details
        2.9.2 Huiwen Major Business
        2.9.3 Huiwen Chondroprotective Agent Product and Services
        2.9.4 Huiwen Chondroprotective Agent Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.10 QJBCHINA
        2.10.1 QJBCHINA Details
        2.10.2 QJBCHINA Major Business
        2.10.3 QJBCHINA Chondroprotective Agent Product and Services
        2.10.4 QJBCHINA Chondroprotective Agent Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.11 Meitek (Synutra International)
        2.11.1 Meitek (Synutra International) Details
        2.11.2 Meitek (Synutra International) Major Business
        2.11.3 Meitek (Synutra International) Chondroprotective Agent Product and Services
        2.11.4 Meitek (Synutra International) Chondroprotective Agent Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.12 Hengjie Bio-Pharmaceuticals
        2.12.1 Hengjie Bio-Pharmaceuticals Details
        2.12.2 Hengjie Bio-Pharmaceuticals Major Business
        2.12.3 Hengjie Bio-Pharmaceuticals Chondroprotective Agent Product and Services
        2.12.4 Hengjie Bio-Pharmaceuticals Chondroprotective Agent Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.13 Nippon Zoki
        2.13.1 Nippon Zoki Details
        2.13.2 Nippon Zoki Major Business
        2.13.3 Nippon Zoki Chondroprotective Agent Product and Services
        2.13.4 Nippon Zoki Chondroprotective Agent Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.14 GGI
        2.14.1 GGI Details
        2.14.2 GGI Major Business
        2.14.3 GGI Chondroprotective Agent Product and Services
        2.14.4 GGI Chondroprotective Agent Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.15 Summit Nutritionals
        2.15.1 Summit Nutritionals Details
        2.15.2 Summit Nutritionals Major Business
        2.15.3 Summit Nutritionals Chondroprotective Agent Product and Services
        2.15.4 Summit Nutritionals Chondroprotective Agent Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.16 Sioux Pharm
        2.16.1 Sioux Pharm Details
        2.16.2 Sioux Pharm Major Business
        2.16.3 Sioux Pharm Chondroprotective Agent Product and Services
        2.16.4 Sioux Pharm Chondroprotective Agent Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.17 Ruikangda Biochemical
        2.17.1 Ruikangda Biochemical Details
        2.17.2 Ruikangda Biochemical Major Business
        2.17.3 Ruikangda Biochemical Chondroprotective Agent Product and Services
        2.17.4 Ruikangda Biochemical Chondroprotective Agent Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.18 Guanglong Biochem
        2.18.1 Guanglong Biochem Details
        2.18.2 Guanglong Biochem Major Business
        2.18.3 Guanglong Biochem Chondroprotective Agent Product and Services
        2.18.4 Guanglong Biochem Chondroprotective Agent Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.19 Pacific Rainbow
        2.19.1 Pacific Rainbow Details
        2.19.2 Pacific Rainbow Major Business
        2.19.3 Pacific Rainbow Chondroprotective Agent Product and Services
        2.19.4 Pacific Rainbow Chondroprotective Agent Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

3 Chondroprotective Agent Breakdown Data by Manufacturer
    3.1 Global Chondroprotective Agent Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
    3.2 Global Chondroprotective Agent Revenue by Manufacturer (2019, 2020, 2021, and 2022)
    3.3 Key Manufacturer Market Position in Chondroprotective Agent
    3.4 Market Concentration Rate
        3.4.1 Top 3 Chondroprotective Agent Manufacturer Market Share in 2021
        3.4.2 Top 6 Chondroprotective Agent Manufacturer Market Share in 2021
    3.5 Global Chondroprotective Agent Production Capacity by Company: 2021 VS 2022
    3.6 Manufacturer by Geography: Head Office and Chondroprotective Agent Production Site
    3.7 New Entrant and Capacity Expansion Plans
    3.8 Mergers & Acquisitions

4 Market Analysis by Region
    4.1 Global Chondroprotective Agent Market Size by Region
        4.1.1 Global Chondroprotective Agent Sales in Volume by Region (2017-2028)
        4.1.2 Global Chondroprotective Agent Revenue by Region (2017-2028)
    4.2 North America Chondroprotective Agent Revenue (2017-2028)
    4.3 Europe Chondroprotective Agent Revenue (2017-2028)
    4.4 Asia-Pacific Chondroprotective Agent Revenue (2017-2028)
    4.5 South America Chondroprotective Agent Revenue (2017-2028)
    4.6 Middle East and Africa Chondroprotective Agent Revenue (2017-2028)

5 Market Segment by Type
    5.1 Global Chondroprotective Agent Sales in Volume by Type (2017-2028)
    5.2 Global Chondroprotective Agent Revenue by Type (2017-2028)
    5.3 Global Chondroprotective Agent Price by Type (2017-2028)

6 Market Segment by Application
    6.1 Global Chondroprotective Agent Sales in Volume by Application (2017-2028)
    6.2 Global Chondroprotective Agent Revenue by Application (2017-2028)
    6.3 Global Chondroprotective Agent Price by Application (2017-2028)

7 North America by Country, by Type, and by Application
    7.1 North America Chondroprotective Agent Sales by Type (2017-2028)
    7.2 North America Chondroprotective Agent Sales by Application (2017-2028)
    7.3 North America Chondroprotective Agent Market Size by Country
        7.3.1 North America Chondroprotective Agent Sales in Volume by Country (2017-2028)
        7.3.2 North America Chondroprotective Agent Revenue by Country (2017-2028)
        7.3.3 United States Market Size and Forecast (2017-2028)
        7.3.4 Canada Market Size and Forecast (2017-2028)
        7.3.5 Mexico Market Size and Forecast (2017-2028)

8 Europe by Country, by Type, and by Application
    8.1 Europe Chondroprotective Agent Sales by Type (2017-2028)
    8.2 Europe Chondroprotective Agent Sales by Application (2017-2028)
    8.3 Europe Chondroprotective Agent Market Size by Country
        8.3.1 Europe Chondroprotective Agent Sales in Volume by Country (2017-2028)
        8.3.2 Europe Chondroprotective Agent Revenue by Country (2017-2028)
        8.3.3 Germany Market Size and Forecast (2017-2028)
        8.3.4 France Market Size and Forecast (2017-2028)
        8.3.5 United Kingdom Market Size and Forecast (2017-2028)
        8.3.6 Russia Market Size and Forecast (2017-2028)
        8.3.7 Italy Market Size and Forecast (2017-2028)

9 Asia-Pacific by Region, by Type, and by Application
    9.1 Asia-Pacific Chondroprotective Agent Sales by Type (2017-2028)
    9.2 Asia-Pacific Chondroprotective Agent Sales by Application (2017-2028)
    9.3 Asia-Pacific Chondroprotective Agent Market Size by Region
        9.3.1 Asia-Pacific Chondroprotective Agent Sales in Volume by Region (2017-2028)
        9.3.2 Asia-Pacific Chondroprotective Agent Revenue by Region (2017-2028)
        9.3.3 China Market Size and Forecast (2017-2028)
        9.3.4 Japan Market Size and Forecast (2017-2028)
        9.3.5 Korea Market Size and Forecast (2017-2028)
        9.3.6 India Market Size and Forecast (2017-2028)
        9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
        9.3.8 Australia Market Size and Forecast (2017-2028)

10 South America by Region, by Type, and by Application
    10.1 South America Chondroprotective Agent Sales by Type (2017-2028)
    10.2 South America Chondroprotective Agent Sales by Application (2017-2028)
    10.3 South America Chondroprotective Agent Market Size by Country
        10.3.1 South America Chondroprotective Agent Sales in Volume by Country (2017-2028)
        10.3.2 South America Chondroprotective Agent Revenue by Country (2017-2028)
        10.3.3 Brazil Market Size and Forecast (2017-2028)
        10.3.4 Argentina Market Size and Forecast (2017-2028)

11 Middle East & Africa by Country, by Type, and by Application
    11.1 Middle East & Africa Chondroprotective Agent Sales by Type (2017-2028)
    11.2 Middle East & Africa Chondroprotective Agent Sales by Application (2017-2028)
    11.3 Middle East & Africa Chondroprotective Agent Market Size by Country
        11.3.1 Middle East & Africa Chondroprotective Agent Sales in Volume by Country (2017-2028)
        11.3.2 Middle East & Africa Chondroprotective Agent Revenue by Country (2017-2028)
        11.3.3 Turkey Market Size and Forecast (2017-2028)
        11.3.4 Egypt Market Size and Forecast (2017-2028)
        11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
        11.3.6 South Africa Market Size and Forecast (2017-2028)

12 Raw Material and Industry Chain
    12.1 Raw Material of Chondroprotective Agent and Key Manufacturers
    12.2 Manufacturing Costs Percentage of Chondroprotective Agent
    12.3 Chondroprotective Agent Production Process
    12.4 Chondroprotective Agent Industrial Chain

13 Sales Channel, Distributors, Traders and Dealers
    13.1 Sales Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
    13.2 Chondroprotective Agent Typical Distributors
    13.3 Chondroprotective Agent Typical Customers

14 Research Findings and Conclusion

15 Appendix
    15.1 Methodology
    15.2 Research Process and Data Source
    15.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Chondroprotective Agent Revenue by Type, (USD Million), 2017 & 2021 & 2028
    Table 2. Global Chondroprotective Agent Revenue by Application, (USD Million), 2017 & 2021 & 2028
    Table 3. SANXIN Basic Information, Manufacturing Base and Competitors
    Table 4. SANXIN Major Business
    Table 5. SANXIN Chondroprotective Agent Product and Services
    Table 6. SANXIN Chondroprotective Agent Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 7. WanTuMing Biological Basic Information, Manufacturing Base and Competitors
    Table 8. WanTuMing Biological Major Business
    Table 9. WanTuMing Biological Chondroprotective Agent Product and Services
    Table 10. WanTuMing Biological Chondroprotective Agent Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 11. TSI Group Basic Information, Manufacturing Base and Competitors
    Table 12. TSI Group Major Business
    Table 13. TSI Group Chondroprotective Agent Product and Services
    Table 14. TSI Group Chondroprotective Agent Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 15. Yantai Dongcheng Basic Information, Manufacturing Base and Competitors
    Table 16. Yantai Dongcheng Major Business
    Table 17. Yantai Dongcheng Chondroprotective Agent Product and Services
    Table 18. Yantai Dongcheng Chondroprotective Agent Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 19. Focus Chem Basic Information, Manufacturing Base and Competitors
    Table 20. Focus Chem Major Business
    Table 21. Focus Chem Chondroprotective Agent Product and Services
    Table 22. Focus Chem Chondroprotective Agent Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 23. YBCC Basic Information, Manufacturing Base and Competitors
    Table 24. YBCC Major Business
    Table 25. YBCC Chondroprotective Agent Product and Services
    Table 26. YBCC Chondroprotective Agent Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 27. Runxin Biotechnology Basic Information, Manufacturing Base and Competitors
    Table 28. Runxin Biotechnology Major Business
    Table 29. Runxin Biotechnology Chondroprotective Agent Product and Services
    Table 30. Runxin Biotechnology Chondroprotective Agent Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 31. ISBA Basic Information, Manufacturing Base and Competitors
    Table 32. ISBA Major Business
    Table 33. ISBA Chondroprotective Agent Product and Services
    Table 34. ISBA Chondroprotective Agent Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 35. Huiwen Basic Information, Manufacturing Base and Competitors
    Table 36. Huiwen Major Business
    Table 37. Huiwen Chondroprotective Agent Product and Services
    Table 38. Huiwen Chondroprotective Agent Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 39. QJBCHINA Basic Information, Manufacturing Base and Competitors
    Table 40. QJBCHINA Major Business
    Table 41. QJBCHINA Chondroprotective Agent Product and Services
    Table 42. QJBCHINA Chondroprotective Agent Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 43. Meitek (Synutra International) Basic Information, Manufacturing Base and Competitors
    Table 44. Meitek (Synutra International) Major Business
    Table 45. Meitek (Synutra International) Chondroprotective Agent Product and Services
    Table 46. Meitek (Synutra International) Chondroprotective Agent Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 47. Hengjie Bio-Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 48. Hengjie Bio-Pharmaceuticals Major Business
    Table 49. Hengjie Bio-Pharmaceuticals Chondroprotective Agent Product and Services
    Table 50. Hengjie Bio-Pharmaceuticals Chondroprotective Agent Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 51. Nippon Zoki Basic Information, Manufacturing Base and Competitors
    Table 52. Nippon Zoki Major Business
    Table 53. Nippon Zoki Chondroprotective Agent Product and Services
    Table 54. Nippon Zoki Chondroprotective Agent Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 55. GGI Basic Information, Manufacturing Base and Competitors
    Table 56. GGI Major Business
    Table 57. GGI Chondroprotective Agent Product and Services
    Table 58. GGI Chondroprotective Agent Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 59. Summit Nutritionals Basic Information, Manufacturing Base and Competitors
    Table 60. Summit Nutritionals Major Business
    Table 61. Summit Nutritionals Chondroprotective Agent Product and Services
    Table 62. Summit Nutritionals Chondroprotective Agent Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 63. Sioux Pharm Basic Information, Manufacturing Base and Competitors
    Table 64. Sioux Pharm Major Business
    Table 65. Sioux Pharm Chondroprotective Agent Product and Services
    Table 66. Sioux Pharm Chondroprotective Agent Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 67. Ruikangda Biochemical Basic Information, Manufacturing Base and Competitors
    Table 68. Ruikangda Biochemical Major Business
    Table 69. Ruikangda Biochemical Chondroprotective Agent Product and Services
    Table 70. Ruikangda Biochemical Chondroprotective Agent Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 71. Guanglong Biochem Basic Information, Manufacturing Base and Competitors
    Table 72. Guanglong Biochem Major Business
    Table 73. Guanglong Biochem Chondroprotective Agent Product and Services
    Table 74. Guanglong Biochem Chondroprotective Agent Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 75. Pacific Rainbow Basic Information, Manufacturing Base and Competitors
    Table 76. Pacific Rainbow Major Business
    Table 77. Pacific Rainbow Chondroprotective Agent Product and Services
    Table 78. Pacific Rainbow Chondroprotective Agent Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 79. Global Chondroprotective Agent Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
    Table 80. Global Chondroprotective Agent Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
    Table 81. Market Position of Manufacturers in Chondroprotective Agent, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
    Table 82. Global Chondroprotective Agent Production Capacity by Company, (K Units): 2020 VS 2021
    Table 83. Head Office and Chondroprotective Agent Production Site of Key Manufacturer
    Table 84. Chondroprotective Agent New Entrant and Capacity Expansion Plans
    Table 85. Chondroprotective Agent Mergers & Acquisitions in the Past Five Years
    Table 86. Global Chondroprotective Agent Sales by Region (2017-2022) & (K Units)
    Table 87. Global Chondroprotective Agent Sales by Region (2023-2028) & (K Units)
    Table 88. Global Chondroprotective Agent Revenue by Region (2017-2022) & (USD Million)
    Table 89. Global Chondroprotective Agent Revenue by Region (2023-2028) & (USD Million)
    Table 90. Global Chondroprotective Agent Sales by Type (2017-2022) & (K Units)
    Table 91. Global Chondroprotective Agent Sales by Type (2023-2028) & (K Units)
    Table 92. Global Chondroprotective Agent Revenue by Type (2017-2022) & (USD Million)
    Table 93. Global Chondroprotective Agent Revenue by Type (2023-2028) & (USD Million)
    Table 94. Global Chondroprotective Agent Price by Type (2017-2022) & (US$/Unit)
    Table 95. Global Chondroprotective Agent Price by Type (2023-2028) & (US$/Unit)
    Table 96. Global Chondroprotective Agent Sales by Application (2017-2022) & (K Units)
    Table 97. Global Chondroprotective Agent Sales by Application (2023-2028) & (K Units)
    Table 98. Global Chondroprotective Agent Revenue by Application (2017-2022) & (USD Million)
    Table 99. Global Chondroprotective Agent Revenue by Application (2023-2028) & (USD Million)
    Table 100. Global Chondroprotective Agent Price by Application (2017-2022) & (US$/Unit)
    Table 101. Global Chondroprotective Agent Price by Application (2023-2028) & (US$/Unit)
    Table 102. North America Chondroprotective Agent Sales by Country (2017-2022) & (K Units)
    Table 103. North America Chondroprotective Agent Sales by Country (2023-2028) & (K Units)
    Table 104. North America Chondroprotective Agent Revenue by Country (2017-2022) & (USD Million)
    Table 105. North America Chondroprotective Agent Revenue by Country (2023-2028) & (USD Million)
    Table 106. North America Chondroprotective Agent Sales by Type (2017-2022) & (K Units)
    Table 107. North America Chondroprotective Agent Sales by Type (2023-2028) & (K Units)
    Table 108. North America Chondroprotective Agent Sales by Application (2017-2022) & (K Units)
    Table 109. North America Chondroprotective Agent Sales by Application (2023-2028) & (K Units)
    Table 110. Europe Chondroprotective Agent Sales by Country (2017-2022) & (K Units)
    Table 111. Europe Chondroprotective Agent Sales by Country (2023-2028) & (K Units)
    Table 112. Europe Chondroprotective Agent Revenue by Country (2017-2022) & (USD Million)
    Table 113. Europe Chondroprotective Agent Revenue by Country (2023-2028) & (USD Million)
    Table 114. Europe Chondroprotective Agent Sales by Type (2017-2022) & (K Units)
    Table 115. Europe Chondroprotective Agent Sales by Type (2023-2028) & (K Units)
    Table 116. Europe Chondroprotective Agent Sales by Application (2017-2022) & (K Units)
    Table 117. Europe Chondroprotective Agent Sales by Application (2023-2028) & (K Units)
    Table 118. Asia-Pacific Chondroprotective Agent Sales by Region (2017-2022) & (K Units)
    Table 119. Asia-Pacific Chondroprotective Agent Sales by Region (2023-2028) & (K Units)
    Table 120. Asia-Pacific Chondroprotective Agent Revenue by Region (2017-2022) & (USD Million)
    Table 121. Asia-Pacific Chondroprotective Agent Revenue by Region (2023-2028) & (USD Million)
    Table 122. Asia-Pacific Chondroprotective Agent Sales by Type (2017-2022) & (K Units)
    Table 123. Asia-Pacific Chondroprotective Agent Sales by Type (2023-2028) & (K Units)
    Table 124. Asia-Pacific Chondroprotective Agent Sales by Application (2017-2022) & (K Units)
    Table 125. Asia-Pacific Chondroprotective Agent Sales by Application (2023-2028) & (K Units)
    Table 126. South America Chondroprotective Agent Sales by Country (2017-2022) & (K Units)
    Table 127. South America Chondroprotective Agent Sales by Country (2023-2028) & (K Units)
    Table 128. South America Chondroprotective Agent Revenue by Country (2017-2022) & (USD Million)
    Table 129. South America Chondroprotective Agent Revenue by Country (2023-2028) & (USD Million)
    Table 130. South America Chondroprotective Agent Sales by Type (2017-2022) & (K Units)
    Table 131. South America Chondroprotective Agent Sales by Type (2023-2028) & (K Units)
    Table 132. South America Chondroprotective Agent Sales by Application (2017-2022) & (K Units)
    Table 133. South America Chondroprotective Agent Sales by Application (2023-2028) & (K Units)
    Table 134. Middle East & Africa Chondroprotective Agent Sales by Region (2017-2022) & (K Units)
    Table 135. Middle East & Africa Chondroprotective Agent Sales by Region (2023-2028) & (K Units)
    Table 136. Middle East & Africa Chondroprotective Agent Revenue by Region (2017-2022) & (USD Million)
    Table 137. Middle East & Africa Chondroprotective Agent Revenue by Region (2023-2028) & (USD Million)
    Table 138. Middle East & Africa Chondroprotective Agent Sales by Type (2017-2022) & (K Units)
    Table 139. Middle East & Africa Chondroprotective Agent Sales by Type (2023-2028) & (K Units)
    Table 140. Middle East & Africa Chondroprotective Agent Sales by Application (2017-2022) & (K Units)
    Table 141. Middle East & Africa Chondroprotective Agent Sales by Application (2023-2028) & (K Units)
    Table 142. Chondroprotective Agent Raw Material
    Table 143. Key Manufacturers of Chondroprotective Agent Raw Materials
    Table 144. Direct Channel Pros & Cons
    Table 145. Indirect Channel Pros & Cons
    Table 146. Chondroprotective Agent Typical Distributors
    Table 147. Chondroprotective Agent Typical Customers
List of Figures
    Figure 1. Chondroprotective Agent Picture
    Figure 2. Global Chondroprotective Agent Revenue Market Share by Type in 2021
    Figure 3. Sodium Hyaluronate
    Figure 4. Glucosamine Sulfate
    Figure 5. Chondroitin Sulfate
    Figure 6. Global Chondroprotective Agent Revenue Market Share by Application in 2021
    Figure 7. Hospital
    Figure 8. Ambulatory Surgery Center
    Figure 9. Global Chondroprotective Agent Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
    Figure 10. Global Chondroprotective Agent Revenue and Forecast (2017-2028) & (USD Million)
    Figure 11. Global Chondroprotective Agent Sales (2017-2028) & (K Units)
    Figure 12. Global Chondroprotective Agent Price (2017-2028) & (US$/Unit)
    Figure 13. Global Chondroprotective Agent Production Capacity (2017-2028) & (K Units)
    Figure 14. Global Chondroprotective Agent Production Capacity by Geographic Region: 2022 VS 2028
    Figure 15. Chondroprotective Agent Market Drivers
    Figure 16. Chondroprotective Agent Market Restraints
    Figure 17. Chondroprotective Agent Market Trends
    Figure 18. Global Chondroprotective Agent Sales Market Share by Manufacturer in 2021
    Figure 19. Global Chondroprotective Agent Revenue Market Share by Manufacturer in 2021
    Figure 20. Chondroprotective Agent Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
    Figure 21. Top 3 Chondroprotective Agent Manufacturer (Revenue) Market Share in 2021
    Figure 22. Top 6 Chondroprotective Agent Manufacturer (Revenue) Market Share in 2021
    Figure 23. Global Chondroprotective Agent Sales Market Share by Region (2017-2028)
    Figure 24. Global Chondroprotective Agent Revenue Market Share by Region (2017-2028)
    Figure 25. North America Chondroprotective Agent Revenue (2017-2028) & (USD Million)
    Figure 26. Europe Chondroprotective Agent Revenue (2017-2028) & (USD Million)
    Figure 27. Asia-Pacific Chondroprotective Agent Revenue (2017-2028) & (USD Million)
    Figure 28. South America Chondroprotective Agent Revenue (2017-2028) & (USD Million)
    Figure 29. Middle East & Africa Chondroprotective Agent Revenue (2017-2028) & (USD Million)
    Figure 30. Global Chondroprotective Agent Sales Market Share by Type (2017-2028)
    Figure 31. Global Chondroprotective Agent Revenue Market Share by Type (2017-2028)
    Figure 32. Global Chondroprotective Agent Price by Type (2017-2028) & (US$/Unit)
    Figure 33. Global Chondroprotective Agent Sales Market Share by Application (2017-2028)
    Figure 34. Global Chondroprotective Agent Revenue Market Share by Application (2017-2028)
    Figure 35. Global Chondroprotective Agent Price by Application (2017-2028) & (US$/Unit)
    Figure 36. North America Chondroprotective Agent Sales Market Share by Type (2017-2028)
    Figure 37. North America Chondroprotective Agent Sales Market Share by Application (2017-2028)
    Figure 38. North America Chondroprotective Agent Sales Market Share by Country (2017-2028)
    Figure 39. North America Chondroprotective Agent Revenue Market Share by Country (2017-2028)
    Figure 40. United States Chondroprotective Agent Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 41. Canada Chondroprotective Agent Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 42. Mexico Chondroprotective Agent Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 43. Europe Chondroprotective Agent Sales Market Share by Type (2017-2028)
    Figure 44. Europe Chondroprotective Agent Sales Market Share by Application (2017-2028)
    Figure 45. Europe Chondroprotective Agent Sales Market Share by Country (2017-2028)
    Figure 46. Europe Chondroprotective Agent Revenue Market Share by Country (2017-2028)
    Figure 47. Germany Chondroprotective Agent Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 48. France Chondroprotective Agent Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 49. United Kingdom Chondroprotective Agent Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 50. Russia Chondroprotective Agent Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 51. Italy Chondroprotective Agent Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 52. Asia-Pacific Chondroprotective Agent Sales Market Share by Region (2017-2028)
    Figure 53. Asia-Pacific Chondroprotective Agent Sales Market Share by Application (2017-2028)
    Figure 54. Asia-Pacific Chondroprotective Agent Sales Market Share by Region (2017-2028)
    Figure 55. Asia-Pacific Chondroprotective Agent Revenue Market Share by Region (2017-2028)
    Figure 56. China Chondroprotective Agent Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 57. Japan Chondroprotective Agent Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 58. Korea Chondroprotective Agent Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 59. India Chondroprotective Agent Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 60. Southeast Asia Chondroprotective Agent Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 61. Australia Chondroprotective Agent Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 62. South America Chondroprotective Agent Sales Market Share by Type (2017-2028)
    Figure 63. South America Chondroprotective Agent Sales Market Share by Application (2017-2028)
    Figure 64. South America Chondroprotective Agent Sales Market Share by Country (2017-2028)
    Figure 65. South America Chondroprotective Agent Revenue Market Share by Country (2017-2028)
    Figure 66. Brazil Chondroprotective Agent Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 67. Argentina Chondroprotective Agent Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 68. Middle East & Africa Chondroprotective Agent Sales Market Share by Type (2017-2028)
    Figure 69. Middle East & Africa Chondroprotective Agent Sales Market Share by Application (2017-2028)
    Figure 70. Middle East & Africa Chondroprotective Agent Sales Market Share by Region (2017-2028)
    Figure 71. Middle East & Africa Chondroprotective Agent Revenue Market Share by Region (2017-2028)
    Figure 72. Turkey Chondroprotective Agent Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 73. Egypt Chondroprotective Agent Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 74. Saudi Arabia Chondroprotective Agent Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 75. South Africa Chondroprotective Agent Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 76. Manufacturing Cost Structure Analysis of Chondroprotective Agent in 2021
    Figure 77. Manufacturing Process Analysis of Chondroprotective Agent
    Figure 78. Chondroprotective Agent Industrial Chain
    Figure 79. Sales Channel: Direct Channel vs Indirect Channel
    Figure 80. Methodology
    Figure 81. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

SANXIN
WanTuMing Biological
TSI Group
Yantai Dongcheng
Focus Chem
YBCC
Runxin Biotechnology
ISBA
Huiwen
QJBCHINA
Meitek (Synutra International)
Hengjie Bio-Pharmaceuticals
Nippon Zoki
GGI
Summit Nutritionals
Sioux Pharm
Ruikangda Biochemical
Guanglong Biochem
Pacific Rainbow

Related Reports

Global Chondroprotective Agent Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Chondroprotective Agent Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 23 Aug 2023

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Chondroprotective Agent market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.

Global Chondroprotective Agent Supply, Demand and Key Producers, 2023-2029

Global Chondroprotective Agent Supply, Demand and Key Producers, 2023-2029

date 23 Aug 2023

date Pharma & Healthcare

The global Chondroprotective Agent market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global Chondroprotective Agent Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Chondroprotective Agent Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 13 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Chondroprotective Agent market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Product Tags

chondroprotective agent

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>